Food Triggers Creation of Regulatory T Cells IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.Therapeutic Approach Gives Hope for Multiple Myeloma A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.Cellular 'Relief Valve' A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.Switch Lets Salmonella Fight, Evade Immune System Researchers at the University of Illinois at Chicago have discovered a molecular regulator that allows salmonella bacteria to switch from actively causing disease to lurking in a chronic but asymptomatic state called a biofilm.Tricked-Out Immune Cells Could Attack Cancer New cell-engineering technique may lead to precision immunotherapies.Neural Networks Adapt to the Presence of a Toxic HIV Protein HIV-associated neurocognitive disorders (HAND) afflict approximately half of HIV infected patients.HIV Protein Manipulates Hundreds of Human Genes Findings search for new or improved treatments for patients with AIDS.Breaking the Brain’s Garbage Disposal The children’s ataxia gene problem turned out to be not such a big deal genetically — it was such a slight mutation that it barely changed the way the cells made the protein. Flesh-Eating Bacteria Work Together Scientists recently discovered different strains of deadly flesh-eating bacteria working together to spread infection and they now have a better understanding of the role of the toxins they produce. The discovery could change how the illness and other diseases are treated.Utilizing Antibodies from Ebola Survivors A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University, The Scripps Research Institute and Integral Molecular Inc. have learned that antibodies in the blood of people who have survived a strain of the Ebola virus can kill various types of Ebola.
Circulating Tumor Antigens and their Autoantibody Reactivity as Cancer Markers Samir Hanash, Program Head, Fred Hutchinson Cancer Research Center, speaking at CellTech 2013.
A lesson for cell-signaling studies using advanced detection techniques Thomas Hengstl MSc, Application Specialist Marketing, Tecan Austria
Helping you to shape in vitro models with cell-based assays Christian Oberdanner, Ph.D. Marketing Application Specialist Detection for Tecan Austria
Regulation of antibody immunotherapy by fine-tuning FcR interactions Mark Cragg, Southampton University School of Medicine, speaking at Stem Cells & Bioprocessing 2012.
Immunogenicity Assessment for the Successful Development of Biosimilars Dr Michael Tovey, Institut Andre Lwoff/INSERM, speaking at Stem Cells & Bioprocessing 2012.
Bicyclic Peptides with Antibody-Like Binding Affinity and Specificity Dr Vanessa Baeriswyl, EPFL, speaking at Stem Cells & Bioprocessing Europe 2012.
Proteomic Identification of Putative Biomarkers of Radiotherapy Resistance Lynn Cawkwell, University of Hull, speaking at Systems Biology Europe 2012
Antigen Microarrays for Proteomic Profiling of the Autoimmunity Repertoire Professor Peter Nilsson, Royal Institute of Technology, Stockholm, speaking at Advances in Microarray Technology 2012.
Electrochemical and Optical Multiple Parameters Genosensors: Tools for Disease Predisposition Analysis Valerio Beni, Linkoping University, speaking at Advances in Biodetection and Biosensors 2012.